Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7501–7550 of 76368
Tim Wan tendered to the Board of Directors (the “Board”) of Asana, Inc. (the “Company”) his resignation as Chief Financial Officer of the Company, effective as of September 10, 2024.
Mr. Jolley will continue as an employee of the Company, serving as senior adviser, finance, effective November 1, 2024.
On September 3, 2024, Trevor S. Lang, President of Floor & Decor Holdings, Inc. (the “Company”), informed the Company that he intends to retire from the Company.
On September 1, 2024, Jason O’Byrne, the Chief Financial Officer of Caribou Biosciences, Inc. (the “Company”), informed the Company of his intent to resign from his position, effective September 27, 2024, to pursue another opportunity.
On August 28, 2024, Malcolm Salter informed the Board of Directors (the “Board”) of C4 Therapeutics, Inc. (the “Company”) of his intention to resign from the Board, effective upon the appointment of his successor.
On August 30, 2024, the Company and Mr. Sievers mutually agreed that Mr. Sievers would separate from the Company as its Chief Operating Officer effective September 30, 2024.
On August 30, 2024, Ms. Themis Glatman resigned her position as an officer and Director of the Corporation.
On August 28, 2024, Mr. Bryan Capelli resigned his position as a Director of the Corporation.
Innovid Corp. (“Innovid” or the “Company”) announces that Dave Helmreich, Chief Commercial Officer of the Company, will be leaving the business by mutual consent to pursue other opportunities, effective from the close of business on August 30, 2024.
On August 28, 2024, Mariann Wojtkun Marshall, Vice President and Chief Accounting Officer of The Progressive Corporation (the “Company”), notified the Company of her decision to retire from these positions in mid-2025
Mr. Stein, previously the Chief Operating Officer of the segment, succeeds Daniel Halftermeyer, who is stepping down from the position to focus his time and energies on driving the continued integration of the Company’s Heimbach acquisition and ensuring a successful transition to Mr. Stein.
On August 27, 2024, Amerino Gatti notified the Board of Directors (the “Board”) of Helix Energy Solutions Group, Inc. (“Helix” or the “Company”) of his intention to resign as a director of the Company effective as of August 30, 2024.
Lauren S. Fisher, the Company’s Senior Vice President and Chief Legal Officer will cease serving in her role and will leave the Company, effective as of September 6, 2024.
On August 29, 2024, C. Timothy Trenary, 68, Executive Vice President, Chief Financial Officer of Superior Industries International, Inc. (the “Company” or “Superior”), notified the Company of his intent to retire from his position at Superior effective September 30, 2024.
Mark Austin ceased serving as an executive officer of the Company and as the Company's “co-principal financial officer” and “principal accounting officer” on August 16, 2024.
On August 27, 2024, Roy T. Chen provided notice of his resignation as Chief Talent Officer of Sonendo, Inc. (the “Company”), effective September 6, 2024, to pursue another opportunity.
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
On August 27, 2024, Franklin R. Witney, Christine A. Tsingos, Annette Tumolo and Jami Nachtsheim and on August 29, 2024, Todd R. Nelson each gave notice of his or her resignation from the Board of Directors (the “Board”) of Telesis Bio Inc. (the “Company”) and from each committee of the Board on which he or she served, to be effective immediately
On August 26, 2024, Mr. Kevin Taylor resigned as a director of the Company.
On August 27, 2024, Jan van de Winkel, Ph.D., notified HOOKIPA Pharma Inc. (the “Company”) of his resignation as a director of the Company, effective as of August 30, 2024 at 12:00 p.m. Eastern Time
On August 27, 2024, Timothy Reilly, Ph.D., notified the Company of his resignation as a director of the Company, effective as of the Effective Time.
On August 28, 2024, Steven Carlson and James Tabacchi each resigned as a director of AtlasClear Holdings, Inc. (the “Company”), effective as of such date.
On August 28, 2024, Steven Carlson and James Tabacchi each resigned as a director of AtlasClear Holdings, Inc. (the “Company”), effective as of such date.
On August 27, 2024, Brian Piekos, the Chief Financial Officer and Treasurer of Elicio Therapeutics, Inc. (the “Company”), informed the Company of his intent to resign from his positions, effective September 6, 2024, to pursue another opportunity.
Dr. Auster ceased employment as the Company’s Chief Financial Officer, effective as of August 30, 2024.
replacing Walter R. Bashaw II who, as previously announced, will resign from the Company as of September 6, 2024
Timothy S. Duncan departed his role as President and Chief Executive Officer of the Company, effective as of August 29, 2024.
Robin Raina, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans U. Keller, George W. Hebard III, Priyanka Kaul, Elizabeth A. LaPuma, and Jill M. Krueger ceased to be directors of the Company.
Robin Raina, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans U. Keller, George W. Hebard III, Priyanka Kaul, Elizabeth A. LaPuma, and Jill M. Krueger ceased to be directors of the Company.
Robin Raina, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans U. Keller, George W. Hebard III, Priyanka Kaul, Elizabeth A. LaPuma, and Jill M. Krueger ceased to be directors of the Company.
Robin Raina, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans U. Keller, George W. Hebard III, Priyanka Kaul, Elizabeth A. LaPuma, and Jill M. Krueger ceased to be directors of the Company.
In addition, Amit Kumar Garg resigned as Chief Financial Officer of the Company as of the Effective Date.
Robin Raina, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans U. Keller, George W. Hebard III, Priyanka Kaul, Elizabeth A. LaPuma, and Jill M. Krueger ceased to be directors of the Company.
Robin Raina, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans U. Keller, George W. Hebard III, Priyanka Kaul, Elizabeth A. LaPuma, and Jill M. Krueger ceased to be directors of the Company.
Robin Raina, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans U. Keller, George W. Hebard III, Priyanka Kaul, Elizabeth A. LaPuma, and Jill M. Krueger ceased to be directors of the Company.
Robin Raina, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans U. Keller, George W. Hebard III, Priyanka Kaul, Elizabeth A. LaPuma, and Jill M. Krueger ceased to be directors of the Company.
Robin Raina, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans U. Keller, George W. Hebard III, Priyanka Kaul, Elizabeth A. LaPuma, and Jill M. Krueger ceased to be directors of the Company.
Robin Raina, Hans U. Benz, Rolf Herter, Neil D. Eckert, Pavan Bhalla, Hans U. Keller, George W. Hebard III, Priyanka Kaul, Elizabeth A. LaPuma, and Jill M. Krueger ceased to be directors of the Company.
On August 27, 2024, Mr. James Dolan provided notice of his intention to resign from the Board of Directors of Hall of Fame Resort & Entertainment Company (the “Company”) for health and other personal reasons.
On August 25, 2024, Edward Cong Wang resigned as a member of the Company’s Board of Directors.
On August 27, 2024, Andrew Taub resigned from the Board, effective immediately.
On August 30, 2024, Treasure Global Inc (the “Company”) accepted the resignations of Joseph “Bobby” Banks and Jeremy Roberts as members of the Board of Directors of the Company effective as of August 30, 2024.
On August 30, 2024, Treasure Global Inc (the “Company”) accepted the resignations of Joseph “Bobby” Banks and Jeremy Roberts as members of the Board of Directors of the Company effective as of August 30, 2024.
Blink Charging Co. (the “Company”) is reporting that Brendan Jones, the Company’s President and Chief Executive Officer, informed the Board of Directors of the Company (the “Board”) on August 27, 2024, that he will step down from his role as the Company’s President and Chief Executive Officer and will retire from the Company effective January 31, 2025.
On August 28, 2024, Laurence Hicks notified the board of directors (the “Board”) of Arch Therapeutics, Inc. (the “Company”) that he will resign as a member of the Board effective August 28, 2024.
Effective August 30, 2024, Lisa Embree departed as the Company’s CFO, Executive Vice President, Treasurer and Secretary.
On August 28, 2024, Kurston P. McMurray, Executive Vice President and General Counsel and Secretary, notified NGL Energy Partners LP (the “Partnership”) that he will be resigning from his position with the Partnership effective October 2, 2024 to pursue other interests.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.